Skip to main content

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, Feb. 23 '25)

 


    Antiviral Res

  1. SCHREIBER A, Ludwig S
    Host-targeted antivirals against SARS-CoV-2 in clinical development - Prospect or disappointment?
    Antiviral Res. 2025;235:106101.
    PubMed         Abstract available

  2. WU Q, Wu H, Hu Y, Zheng X, et al
    Immune evasion of Omicron variants JN.1, KP.2, and KP.3 to the polyclonal and monoclonal antibodies from COVID-19 convalescents and vaccine recipients.
    Antiviral Res. 2025 Jan 24:106092. doi: 10.1016/j.antiviral.2025.106092.
    PubMed         Abstract available

  3. XU M, Zhang Z, Sun Y, Mai H, et al
    IgA class switching enhances neutralizing potency against SARS-CoV-2 by increased antibody hinge flexibility.
    Antiviral Res. 2025 Jan 17:106082. doi: 10.1016/j.antiviral.2025.106082.
    PubMed         Abstract available


    Biochemistry

  4. LEE S, Yan S, Dey A, Laederach A, et al
    A Cascade of Conformational Switches in SARS-CoV-2 Frameshifting: Coregulation by Upstream and Downstream Elements.
    Biochemistry. 2025;64:953-966.
    PubMed         Abstract available

  5. DHAKA P, Singh A, Nehul S, Choudhary S, et al
    Disruption of Molecular Interactions between the G3BP1 Stress Granule Host Protein and the Nucleocapsid (NTD-N) Protein Impedes SARS-CoV-2 Virus Replication.
    Biochemistry. 2025;64:823-840.
    PubMed         Abstract available


    Cell

  6. WANG E, Cohen AA, Caldera LF, Keeffe JR, et al
    Designed mosaic nanoparticles enhance cross-reactive immune responses in mice.
    Cell. 2025;188:1036-1050.
    PubMed         Abstract available


    Drug Saf

  7. NAMBASA VP, Gunter HM, Adeyemo MB, Bhawaneedin NY, et al
    Empowering African Expertise: Enhancing Safety Data Integration and Signal Detection for COVID-19 Vaccines Through the African Union Smart Safety Surveillance Joint Signal Management Group.
    Drug Saf. 2025;48:233-249.
    PubMed         Abstract available

  8. BOULEFAA D, Bagheri H, Salvo F, Rabier MB, et al
    Early Detection of Hearing Impairment Signals Post-mRNA COVID-19 Vaccination: A Disproportionality Analysis Study on French Pharmacovigilance Database.
    Drug Saf. 2025;48:251-263.
    PubMed         Abstract available


    Epidemiol Infect

  9. SIMMS I, Charlett A, Colon-Gonzalez FJ, Blomquist PB, et al
    Adapting the Flexible Farrington Algorithm for daily situational awareness and alert system to support public health decision-making during the SARS-CoV-2 epidemic in England.
    Epidemiol Infect. 2025;153:e28.
    PubMed         Abstract available

  10. HAYES J, Lee SS, Carnevale J, Shamir D, et al
    Performance and functional assessment of the Kimera P-IV point-of-care plasmonic qPCR prototype for ultra rapid pathogen detection of chlamydia trachomatis.
    Epidemiol Infect. 2025;153:e27.
    PubMed         Abstract available


    J Infect

  11. MONK EJM, Foulkes S, Munro K, Atti A, et al
    Characterisation of the SARS-CoV-2 pandemic in healthcare workers within the United Kingdom: risk factors for infection during four successive waves.
    J Infect. 2024 Dec 27:106393. doi: 10.1016/j.jinf.2024.106393.
    PubMed         Abstract available

  12. MENSAH AA, Stowe J, Brown K, LopezBernal J, et al
    COVID-19 reinfection in pregnancy: assessment of Severity and pregnancy outcomes in England.
    J Infect. 2024 Dec 27:106392. doi: 10.1016/j.jinf.2024.106392.
    PubMed         Abstract available

  13. RUBIO R, Yavlinsky A, Zamudio ME, Molinos-Albert LM, et al
    Initial antigen encounter determines robust T-cell immunity against SARS-CoV-2 BA.2.86 variant three years later.
    J Infect. 2024 Dec 31:106402. doi: 10.1016/j.jinf.2024.106402.
    PubMed         Abstract available

  14. JORDA A, Prager M, Pracher L, Haselwanter P, et al
    Immunogenicity, Safety, and Reactogenicity of Concomitant Administration of the Novavax Vaccine against Omicron XBB.1.5 (NVX-CoV2601) and a 20-valent Pneumococcal Conjugate Vaccine in Adults Aged >/=60 Years: A Randomised, Double-blind, Placebo-contro
    J Infect. 2025 Jan 3:106405. doi: 10.1016/j.jinf.2024.106405.
    PubMed         Abstract available

  15. ONG DS, Harris M, Hart JD, Russell FM, et al
    Lack of correlation between school reopening and trends in adult COVID-19 hospitalisations and death rates during the Delta and early Omicron periods: an ecological analysis of five countries.
    J Infect. 2025 Jan 6:106390. doi: 10.1016/j.jinf.2024.106390.
    PubMed         Abstract available

  16. NURMI V, Mayne R, Knight C, Almonacid-Mendoza HL, et al
    Individual patient and donor seroprofiles in convalescent plasma treatment of COVID-19 in REMAP-CAP clinical trial.
    J Infect. 2025 Jan 9:106412. doi: 10.1016/j.jinf.2025.106412.
    PubMed         Abstract available

  17. WENDEL-GARCIA PD, Ceccato A, Motos A, Franch-Llasat D, et al
    Empirical antibiotic therapy improves outcomes in mechanically ventilated patients with COVID-19: An emulated targeted trial within a prospective, multicentre cohort study.
    J Infect. 2025 Jan 13:106411. doi: 10.1016/j.jinf.2025.106411.
    PubMed         Abstract available

  18. ROMERO-RAMIREZ A, Somasundaran A, Kontogianni K, Parkes J, et al
    Evaluation of the diagnostic accuracy of Xpert(R) Mpox and STANDARD M10 MPX/OPX for the detection of monkeypox virus.
    J Infect. 2025 Jan 15:106413. doi: 10.1016/j.jinf.2025.106413.
    PubMed         Abstract available

  19. FENG S, Bibi S, Aley PK, Cappuccini F, et al
    Safety and humoral immunogenicity of the ChAdOx1 nCoV-19 vaccine administered as a fourth dose booster following two doses of ChAdOx1 nCoV-19 and a third dose of BNT162b2 (COV009): A prospective cohort study.
    J Infect. 2025;90:106423.
    PubMed         Abstract available

  20. BENNETT C, Chau G, Clayton E, Chu L, et al
    Safety and Immunogenicity of Omicron Protein Vaccines in mRNA-Vaccinated Adolescents: A Phase 3, Randomised Trial.
    J Infect. 2025 Jan 26:106428. doi: 10.1016/j.jinf.2025.106428.
    PubMed         Abstract available

  21. WILLIAMS KV, Krauland MG, Nowalk MP, Harrison LH, et al
    Increasing child vaccination coverage can reduce influenza cases across age groups: An agent-based modeling study.
    J Infect. 2025;90:106443.
    PubMed         Abstract available


    J Infect Dis

  22. LEVENE RE, DeVincenzo J, Conery AL, Ahmad A, et al
    EDP-938 Has a High Barrier to Resistance in Healthy Adults Experimentally Infected with Respiratory Syncytial Virus.
    J Infect Dis. 2025;231:e290-e298.
    PubMed         Abstract available

  23. MAVIAN CN, Tagliamonte MS, Bassett M, Alam M, et al
    COVID-19 lineages in a minimally vaccinated island population: Genomic epidemiology of SARS-CoV-2 in Haiti.
    J Infect Dis. 2024 Oct 23:jiae520. doi: 10.1093.
    PubMed         Abstract available

  24. HAGER DN, Zhu Y, Sohn I, Stubblefield WB, et al
    Effectiveness of the original monovalent mRNA COVID-19 vaccination series against hospitalization for COVID-19-associated venous thromboembolism.
    J Infect Dis. 2024 Oct 15:jiae502. doi: 10.1093.
    PubMed         Abstract available

  25. KANG HM, Kim HJ, Jung J, Ahn JY, et al
    Natural Boosting and the Immunogenicity of the XBB.1.5 Monovalent Vaccine in the Coronavirus Disease 2019 Endemic Era: A Longitudinal Observational Study.
    J Infect Dis. 2024 Nov 29:jiae536. doi: 10.1093.
    PubMed         Abstract available


  26. Correction to: An Update on Highly Pathogenic Avian Influenza A(H5N1) Virus, Clade 2.3.4.4b.
    J Infect Dis. 2025 Feb 17:jiaf085. doi: 10.1093.
    PubMed        


    J Virol Methods

  27. FRAISSE A, Guillier L, Cordevant C, Le Poder S, et al
    Impedance-based method for the quantification of infectious SARS-CoV-2.
    J Virol Methods. 2025;333:115110.
    PubMed         Abstract available

  28. HOFF K, Ding X, Liu XL, Lin JY, et al
    Rapid, inexpensive multiplex pathogen detection using resequencing microarrays.
    J Virol Methods. 2025;333:115109.
    PubMed         Abstract available

  29. NGUYEN MA, Williams C, Gard AL, Connor JH, et al
    Endothelial growth media components alter SARS-CoV-2 spike-directed growth kinetics.
    J Virol Methods. 2025;333:115111.
    PubMed         Abstract available

  30. IBRAHIM S, Spackman E, Suarez DL, Goraichuk IV, et al
    Evaluation of an N1 NA antibody-specific enzyme-linked lectin assay for detection of H5N1 highly pathogenic avian influenza virus infection in vaccinated birds.
    J Virol Methods. 2025 Feb 14:115127. doi: 10.1016/j.jviromet.2025.115127.
    PubMed         Abstract available

  31. LOPEZ KP, Cool KR, Bold D, Gaudreault NN, et al
    Detection of SARS-CoV-2- specific antibodies in domestic cats using different ELISA tests.
    J Virol Methods. 2025;333:115099.
    PubMed         Abstract available


    Minerva Pediatr (Torino)

  32. GIALLONARDO M, Uccella S, De Carli F, Nobili L, et al
    Stress symptoms and Coronavirus disease 2019 (COVID-19): a comparative study between Attention Deficit Hyperactivity Disorder and typically developing children and adolescents.
    Minerva Pediatr (Torino). 2025;77:62-67.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  33. NARAHARISETTI R, Weinberg M, Stoddard B, Stobierski MG, et al
    Highly Pathogenic Avian Influenza A(H5N1) Virus Infection of Indoor Domestic Cats Within Dairy Industry Worker Households - Michigan, May 2024.
    MMWR Morb Mortal Wkly Rep. 2025;74:61-65.
    PubMed         Abstract available


    PLoS Comput Biol

  34. GAO S, Chakraborty AK, Greiner R, Lewis MA, et al
    Early detection of disease outbreaks and non-outbreaks using incidence data: A framework using feature-based time series classification and machine learning.
    PLoS Comput Biol. 2025;21:e1012782.
    PubMed         Abstract available

  35. SHEN X, Rumack A, Wilder B, Tibshirani RJ, et al
    Nowcasting reported covid-19 hospitalizations using de-identified, aggregated medical insurance claims data.
    PLoS Comput Biol. 2025;21:e1012717.
    PubMed         Abstract available


    PLoS One

  36. LI J, Tao L, Zhou Y, Zhu Y, et al
    Identification of biomarkers in Alzheimer's disease and COVID-19 by bioinformatics combining single-cell data analysis and machine learning algorithms.
    PLoS One. 2025;20:e0317915.
    PubMed         Abstract available

  37. IMTIAZ K, Farooqui N, Ahmed K, Zhamalbekova A, et al
    Analysis of differential expression of matrix metalloproteinases and defensins in the nasopharyngeal milieu of mild and severe COVID-19 cases.
    PLoS One. 2025;20:e0304311.
    PubMed         Abstract available

  38. OYASU A, Salter-Volz A, Yeh C, Muhammad LN, et al
    Evaluating Covid-19 publications for sex and gender-specific health content: A bibliometric analysis.
    PLoS One. 2025;20:e0316812.
    PubMed         Abstract available

  39. HUANG X, Gao Q, Wang D
    The impact of top management team tenure heterogeneity on innovation efficiency of declining firms.
    PLoS One. 2025;20:e0313624.
    PubMed         Abstract available

  40. WANDER PL, Lowy E, Korpak A, Beste LA, et al
    SARS-CoV-2 infection is associated with higher chance of diabetes remission among Veterans with incident diabetes.
    PLoS One. 2025;20:e0317348.
    PubMed         Abstract available

  41. GALAL N, Beshay BY, Soliman O, Ismail MI, et al
    Evaluating the structure-based virtual screening performance of SARS-CoV-2 main protease: A benchmarking approach and a multistage screening example against the wild-type and Omicron variants.
    PLoS One. 2025;20:e0318712.
    PubMed         Abstract available

  42. MCCONNELL J, Rushton A, Noblet T, Pacey V, et al
    Perceptions, experiences, barriers, facilitators, learning outcomes, and modes of assessment of digital clinical placements for pre-registration physiotherapy students internationally: a systematic review protocol.
    PLoS One. 2025;20:e0319024.
    PubMed         Abstract available

  43. VASHI B, Pettrone K, Wilson CS, Chenoweth JG, et al
    COVID-19 symptom severity and duration among outpatients, July 2021-May 2023: The PROTECT observational study.
    PLoS One. 2025;20:e0314518.
    PubMed         Abstract available

  44. PANAZAN O, Gheorghe C
    Impact of geopolitical risks and innovation on global defense stock return.
    PLoS One. 2025;20:e0312155.
    PubMed         Abstract available

  45. DARJANA D, Wiyono SK, Koesrindartoto DP
    Research on the impact of COVID-19 on the financial system: Evidence from Indonesia.
    PLoS One. 2025;20:e0301123.
    PubMed         Abstract available

  46. SHI H, Zhang X, Ross TM
    A single dose of inactivated influenza virus vaccine expressing COBRA hemagglutinin elicits broadly-reactive and long-lasting protection.
    PLoS One. 2025;20:e0308680.
    PubMed         Abstract available

  47. IRGENS MS, O'Neill RM, Ruiz JM
    Multi-level quality assessment of United States COVID-19 epidemiological surveillance.
    PLoS One. 2025;20:e0319263.
    PubMed         Abstract available

  48. SODHI S, Chamali R, Praveen D, Sharma M, et al
    Does integration matter? an international cross-sectional study on the relationship between perceived public health and primary care integration and COVID-19 vaccination rates.
    PLoS One. 2025;20:e0317970.
    PubMed         Abstract available

  49. HWANG SH, Chang Y, Bai H, Yun J, et al
    Impact of COVID-19 on admission and in-hospital mortality of patients with acute myocardial infarction in Korea: An interrupted time series analysis.
    PLoS One. 2025;20:e0316943.
    PubMed         Abstract available

  50. SENTIEIRO ML, Cunha Ferreira L, Pires de Miranda M, Araujo Vitoria B, et al
    Couples and parenting dynamics during Covid-19 pandemic: A systematic review of the literature.
    PLoS One. 2025;20:e0315417.
    PubMed         Abstract available

  51. AZI LMTA, Ferreira TS, Cerqueira-Silva T, Diego LAS, et al
    Prevalence of burnout syndrome in Brazilian anesthesiologists during the COVID-19 pandemic: A cross-sectional survey.
    PLoS One. 2025;20:e0313538.
    PubMed         Abstract available

  52. TIMONEDA JC, Vera SV
    Behind the mask: Random and selective masking in transformer models applied to specialized social science texts.
    PLoS One. 2025;20:e0318421.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  53. GONZALES JE 2ND, Kim I, Bastiray A, Hwang W, et al
    Evolutionary rewiring of the dynamic network underpinning allosteric epistasis in NS1 of the influenza A virus.
    Proc Natl Acad Sci U S A. 2025;122:e2410813122.
    PubMed         Abstract available


    Vaccine

  54. ZHANG Y, Li X, Yang Y, Yin Y, et al
    Impact of SARS-CoV-2 inactivated vaccine on symptoms following omicron variant breakthrough infection.
    Vaccine. 2025;48:126722.
    PubMed         Abstract available

  55. DE OLIVEIRA PMN, Hartmann K, Bhamare C, Lucchesi MBB, et al
    Active vaccine safety surveillance in low- and middle-income countries: Challenges for vaccine manufacturers from emerging countries.
    Vaccine. 2025;48:126727.
    PubMed         Abstract available

  56. DOS SANTOS CVB, Coelho LE, de Noronha TG, Goedert GT, et al
    The impact of vaccination on the length of stay of hospitalized COVID-19 patients in Brazil.
    Vaccine. 2025;48:126735.
    PubMed         Abstract available

  57. SHAH RM, Parzen-Johnson S, Sun S, Patel SJ, et al
    Childhood opportunity index and vaccine uptake in pediatric COVID-19 hospitalizations.
    Vaccine. 2025;48:126734.
    PubMed         Abstract available

  58. RAINERI D, Mazzucca CB, Moia R, Bruna R, et al
    Impairment of the T cell memory response in chronic lymphocytic leukemia patients after SARS-CoV-2 vaccination.
    Vaccine. 2025;48:126723.
    PubMed         Abstract available

  59. PROSSER LA, Perroud J, Chung GS, Gebremariam A, et al
    The cost-effectiveness of vaccination against COVID-19 illness during the initial year of vaccination.
    Vaccine. 2025;48:126725.
    PubMed         Abstract available

  60. ADU P, Popoola T, Iqbal N, Roemer A, et al
    A cross-country network analysis of disease infodemics: Looking through the lens of the COVID-19 pandemic.
    Vaccine. 2025;48:126733.
    PubMed         Abstract available

  61. OKA E, Ueda Y, Yagi A, Machida M, et al
    Challenges to promoting maternal respiratory syncytial virus vaccination in Japan.
    Vaccine. 2025;48:126767.
    PubMed         Abstract available

  62. WANG B, Lassi Z, Andraweera P, Chen G, et al
    Pregnant women's choices for preventing respiratory syncytial virus (RSV).
    Vaccine. 2025;48:126790.
    PubMed         Abstract available

  63. MWENDA JM, Mandomando I, Worwui AK, Gacic-Dobo M, et al
    A decade of rotavirus vaccination in the World Health Organization African Region: An in-depth analysis of vaccine coverage from 2012 to 2023.
    Vaccine. 2025 Jan 30:126768. doi: 10.1016/j.vaccine.2025.126768.
    PubMed         Abstract available

  64. CHANG C, Patel H, Ferrari A, Scalzo T, et al
    sa-mRNA influenza vaccine raises a higher and more durable immune response than mRNA vaccine in preclinical models.
    Vaccine. 2025;51:126883.
    PubMed         Abstract available

  65. APPEL AM, Janbek J, Laursen TM, Gasse C, et al
    Dementia and influenza vaccination: Time trends and predictors of vaccine uptake among older adults.
    Vaccine. 2025;51:126864.
    PubMed         Abstract available

  66. TAAFFE J, Goldin S, Lambach P, Sparrow E, et al
    Global production capacity of seasonal and pandemic influenza vaccines in 2023.
    Vaccine. 2025;51:126839.
    PubMed         Abstract available

  67. ZHAO T, Liu X, Huang X, Wang L, et al
    Development and evaluation of mosaic VLPs vaccine for enhanced broad-Spectrum immunity against influenza B virus lineages in mice.
    Vaccine. 2025;51:126882.
    PubMed         Abstract available


    Virus Res

  68. GHAMMAZ H, Melloul M, Mbarki A, Hemlali M, et al
    Genomic evolution of SARS-CoV-2 in Morocco: Insights from whole genome sequences collected from 2020 to 2024.
    Virus Res. 2025;353:199530.
    PubMed         Abstract available

Comments

Popular posts from this blog

#USA, APHIS Confirms {Avian #Influenza #H5N1} #D11 #Genotype in Dairy #Cattle in #Nevada

On January 31, 2025, the USDA Animal and Plant Health Inspection Service (APHIS) National Veterinary Services Laboratories (NVSL) confirmed by whole genome sequence the first detection of highly pathogenic avian influenza (HPAI) H5N1 clade 2.3.4.4b, genotype D1.1 in dairy cattle .  This confirmation was a result of State tracing and investigation, following an initial detection on silo testing under the USDA’s National Milk Testing Strategy (NMTS) in Nevada.  USDA APHIS continues to work with the Nevada Department of Agriculture by conducting additional on-farm investigation, testing, and gathering additional epidemiological information to better understand this detection and limit further disease spread.  This is the first detection of this virus genotype in dairy cattle (all previous detections in dairy cattle have been HPAI H5N1 clade 2.3.4.4b, genotype B3.13 ).  Genotype D1.1 represents the predominant genotype in the North American flyways this past fall an...

#USA, After #Birdflu Detected in Local #Cat, County #Health Officials Say #Pet Owners Should Contact Veterinarian When Their Pets are Sick

Redwood City — State veterinary and health officials have confirmed a case of H5N1 (bird flu) in a domestic stray cat in San Mateo County.  The infection, which is not related to the recent instance of bird flu in a backyard flock , was found in a stray cat in Half Moon Bay that had been taken in by a family .  When it showed symptoms, they took it to Peninsula Humane Society, whose veterinarians examined it and requested testing. Lab results confirmed H5N1.  It is not known how the cat was infected and it was euthanized due to its condition. Cats may be exposed to bird flu by consuming infected bird , being in environments contaminated with the virus and consuming unpasteurized milk from infected cows or raw food. Inside domestic animals, such as cats and dogs, that go outside are also at risk of infection.​​​​​​​ According to the Centers for Disease Control and Prevention, the risk of cats spreading H5N1 to people is extremely low, though it is possible for cats to spre...

#USA, Novel #Influenza A #H5N1 Virus: One Pediatric Case in #California {FluView}

 {Excerpt} One confirmed human infection with influenza A(H5) virus was reported to CDC this week. To date, human-to-human transmission of influenza A(H5) virus has not been identified in the United States. This case was reported by the California Department of Public Health and occurred in a child less than 18 years old with no known contact with influenza A(H5N1) virus-infected animals or humans . The investigation into the source of infection for this case is ongoing , and no human-to-human transmission has been identified. A specimen from the individual was tested at a public health laboratory using the CDC influenza A(H5) assay before being sent to CDC for further testing. The specimen was positive for influenza A(H5) virus using diagnostic RT-PCR at CDC. Additional analysis including genetic sequencing is underway. In response to this detection, additional case investigation and contact monitoring are being conducted by public health officials in California. There have now be...